BCBS Michigan Medical Policy Updates – August 2018

Click here to view the Blue Cross Blue Shield Michigan Medical Policy Updates »

August 2018 BCBS Michigan Medical Policy Updates:

• Aquablation (Transurethral Waterjet Ablation) of the Prostate
• BMT – Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia
• BMT- Hematopoietic Cell Transplantation for Autoimmune Disease
• BMT/Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma – Autologous or Allogeneic
• Bone Turnover Markers for Diagnosis and Management of Osteoporosis and Diseases Associated with High Bone Turnover
• Cranial Orthosis (Helmet or Band Therapy) as a Treatment of Plagiocephaly
• Electrical Stimulation for the Treatment of Arthritis
• Endometrial Ablation
• Genetic Testing – Preimplantation
• Genetic Testing- Molecular Markers in Fine Needle Aspirates (FNA) of the Thyroid
• Speech/Swallowing Therapy
• Stretch Devices for the Treatment of Joint Stiffness or Contracture
• Temporomandibular Joint Dysfunction (TMJD) Testing and Treatment

Added 8/24/2018;

• Artificial Intervertebral Discs-Lumbar Spine
• Balloon Dilation of the Eustachian Tube (BDET)
• BMT – Hematopoietic Cell Transplantation for Germ-Cell Tumors
• BMT – Hematopoietic Cell Transplantation for Hodgkin Lymphoma
• Bone Marrow Transplantation for Malignant Astrocytomas and Gliomas, Autologous
• Cardiac Rehabilitation, Outpatient
• Chemical Peels
• Coverage of Routine Services Associated with Clinical Trials
• Deep Brain Stimulation
• Endothelial Function Assessment
• Endovascular Procedures for Intracranial Arterial Disease (Atherosclerosis and Aneurysms)
• Endovascular Therapies For Extracranial Vertebral Artery Disease
• Extracorporeal Liver Support Devices
• Lutathera® (lutetium Lu 177 dotatate)
• Perirectal Spacer for Radiation Therapy Treatment of Prostate Cancer (SpaceOAR®)
• Peroral Endoscopic Myotomy for Treatment of Esophageal Achalasia
• Secretory Type II Phospholipase A2 (sPLA2-IIA) Testing to Predict Susceptibility to Coronary Artery Disease
• Transplantation for Myelodysplastic Syndromes and Myeloproliferative Neoplasms, Allogeneic

Added 8/27/2018;

• Actigraphy For Obstructive Sleep Apnea and Sleep Disorders
• BCR-ABL1 Testing in Chronic Myelogenous Leukemia and Acute Lymphoblastic Leukemia
• Fecal Microbiota Transplantation (Fecal Bacteriotherapy)
• Frenulum Surgery
• Genetic Testing for Dilated Cardiomyopathy
• Genetic Testing for Duchenne and Becker Muscular Dystrophy
• Genetic Testing for Epilepsy
• Genetic Testing for FMR1 mutations (including Fragile X Syndrome)
• Genetic Testing for Hereditary Hemochromatosis
• Genetic Testing for Warfarin Dosing
• Home Uterine Activity Monitoring
• Implantable Cardioverter Defibrillator (ICD), Including Subcutaneous ICDs
• Interferential Stimulation (IFS) (Sympathetic Therapy)
• Interspinous/Interlaminar Stabilization/Distraction Devices (Spacers)
• Intraocular Radiation Therapy for Age-Related Macular Degeneration
• Islet Transplantation

Click here to view the Blue Cross Blue Shield Michigan Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.